{"schema_version":"secwatch.filing_event.v1","accession":"0001279569-23-000434","form_type":"8-K","ticker":"CWBHF","cik":"0001750155","company_name":"Charlotte's Web Holdings, Inc.","filed_at":"2023-04-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.374401+00:00","generated_at":"2026-06-17T04:39:44.197471+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Charlotte's Web forms JV with BAT and AJNA to develop FDA-approved hemp botanical drug","bullets":["BAT invests $10M for 20% preferred equity; Charlotte's Web and AJNA each hold 40% voting common.","JV plans FDA IND filing and Phase I clinical trial in 2023 targeting a neurological condition.","Dr. Orrin Devinsky, lead Epidiolex investigator, to head JV clinical and regulatory strategy.","BAT is a related party due to its $56.8M convertible debenture; JV exempt from formal valuation and minority approval.","Charlotte's Web contributes proprietary hemp IP and clinical data; AJNA provides lab and regulatory services."],"urls":{"canonical":"https://secwatch.observer/filing/0001279569-23-000434","json":"https://secwatch.observer/filing/0001279569-23-000434.json","markdown":"https://secwatch.observer/filing/0001279569-23-000434.md","text":"https://secwatch.observer/filing/0001279569-23-000434.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1750155/000127956923000434/0001279569-23-000434-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1750155/000127956923000434/form8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T04:39:44.197471+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}